Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL965364 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL964318 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL966172 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL965268 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL963273 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL6552177 | 1.00 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL6118647 | 0.96 | ANPEP (0.49) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL11677240 | 0.96 | ANPEP (0.49) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL11523051 | 0.96 | ANPEP (0.49) | GPR84FFAR1FFAR4ANPEPERAP2 | |
| SCHEMBL11525927 | 0.96 | GPR84 (0.47) | GPR84FFAR1FFAR4ANPEPERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150183721-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-07-02 | — | — | US | claimed |
| US-20150183721-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-07-02 | — | — | US | disclosed |
| US-20150183721-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-07-02 | — | — | US | disclosed |
| US-20150183721-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-07-02 | — | — | US | disclosed |
| EP-2462105-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) | 2012-06-13 | — | — | EP | disclosed |
| US-20120129947-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-05-24 | — | — | US | disclosed |
| US-20120129947-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-05-24 | — | — | US | disclosed |
| US-20120129947-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-05-24 | — | — | US | disclosed |
| WO-2011016033-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183721-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | AADAT, ABAT, ADH1A | GPR84 877/4885FFAR1 1468/4885FFAR4 2405/4885 |
| US-20120129947-A1 | AMINO-ALCOHOL ANALOGUES AND USES THEREOF | AADAT, ABAT, ADH1A | GPR84 877/4885FFAR1 1468/4885FFAR4 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.